Pathogenic mechanisms of B-lymphocyte dysfunction in HIV disease

Journal of Allergy and Clinical Immunology

Volumn 122, Issue 1, 2008, Pages 12-19

  Moir, Susan ^a   Fauci, Anthony S ^a  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

apoptosis; B cells; HIV; immune activation; immunopathogenesis; lymphopenia

Indexed keywords

ANTIBODY RESPONSE; B LYMPHOCYTE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOPATHOGENESIS; LYMPHOCYTE SUBPOPULATION; LYMPHOCYTOPENIA; OPPORTUNISTIC INFECTION; PRIORITY JOURNAL; REVIEW; VIRUS CELL INTERACTION;

ANIMALS; ANTIGENS, CD; APOPTOSIS; B-LYMPHOCYTE SUBSETS; B-LYMPHOCYTES; GENE EXPRESSION PROFILING; HIV; HIV INFECTIONS; HUMANS; LYMPHOCYTE ACTIVATION; SUPERANTIGENS; T-LYMPHOCYTES;

EID: 46049114456     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaci.2008.04.034     Document Type: Review

References (80)

1. De Milito A. B lymphocyte dysfunctions in HIV infection. Curr HIV Res 2 (2004) 11-21
2. Fauci A.S., Mavilio D., and Kottilil S. NK cells in HIV infection: paradigm for protection or targets for ambush. Nat Rev Immunol 5 (2005) 835-843
3. Grossman Z., Meier-Schellersheim M., Paul W.E., and Picker L.J. Pathogenesis of HIV infection: what the virus spares is as important as what it destroys. Nat Med 12 (2006) 289-295
4. Papagno L., Spina C.A., Marchant A., Salio M., Rufer N., Little S., et al. Immune activation and CD8+ T-cell differentiation towards senescence in HIV-1 infection. PLoS Biol 2 (2004) E20
5. Lane H.C., Masur H., Edgar L.C., Whalen G., Rook A.H., and Fauci A.S. Abnormalities of B-cell activation and immunoregulation in patients with the acquired immunodeficiency syndrome. N Engl J Med 309 (1983) 453-458
6. Ng V.L. B-lymphocytes and autoantibody profiles in HIV disease. Clin Rev Allergy Immunol 14 (1996) 367-384
7. Racz P., Tenner-Racz K., van Vloten F., Schmidt H., Dietrich M., Gluckman J.C., et al. Lymphatic tissue changes in AIDS and other retrovirus infections: tools and insights. Lymphology 23 (1990) 85-91
8. Pantaleo G., Graziosi C., Demarest J.F., Cohen O.J., Vaccarezza M., Gantt K., et al. Role of lymphoid organs in the pathogenesis of human immunodeficiency virus (HIV) infection. Immunol Rev 140 (1994) 105-130
9. Moir S., Malaspina A., Ogwaro K.M., Donoghue E.T., Hallahan C.W., Ehler L.A., et al. HIV-1 induces phenotypic and functional perturbations of B cells in chronically infected individuals. Proc Natl Acad Sci U S A 98 (2001) 10362-10367
10. Fournier A.M., Fondere J.M., Alix-Panabieres C., Merle C., Baillat V., Huguet M.F., et al. Spontaneous secretion of immunoglobulins and anti-HIV-1 antibodies by in vivo activated B lymphocytes from HIV-1-infected subjects: monocyte and natural killer cell requirement for in vitro terminal differentiation into plasma cells. Clin Immunol 103 (2002) 98-109
11. Shirai A., Cosentino M., Leitman-Klinman S.F., and Klinman D.M. Human immunodeficiency virus infection induces both polyclonal and virus-specific B cell activation. J Clin Invest 89 (1992) 561-566
12. Martinez-Maza O., and Breen E.C. B-cell activation and lymphoma in patients with HIV. Curr Opin Oncol 14 (2002) 528-532
13. Chong Y., Nabeshima S., Furusyo N., Murata M., Yamaji K., and Hayashi J. Downregulation of CXCR5 in CD27- B cells of HIV-1 infected patients. J Med Virol 73 (2004) 362-367
14. Jacobson M.A., Khayam-Bashi H., Martin J.N., Black D., and Ng V. Effect of long-term highly active antiretroviral therapy in restoring HIV-induced abnormal B-lymphocyte function. J Acquir Immune Defic Syndr 31 (2002) 472-477
15. Nilssen D.E., Oktedalen O., and Brandtzaeg P. Intestinal B cell hyperactivity in AIDS is controlled by highly active antiretroviral therapy. Gut 53 (2004) 487-493
16. Notermans D.W., de Jong J.J., Goudsmit J., Bakker M., Roos M.T., Nijholt L., et al. Potent antiretroviral therapy initiates normalization of hypergammaglobulinemia and a decline in HIV type 1-specific antibody responses. AIDS Res Hum Retroviruses 17 (2001) 1003-1008
17. Morris L., Binley J.M., Clas B.A., Bonhoeffer S., Astill T.P., Kost R., et al. HIV-1 antigen-specific and -nonspecific B cell responses are sensitive to combination antiretroviral therapy. J Exp Med 188 (1998) 233-245
18. Moir S., Malaspina A., Pickeral O.K., Donoghue E.T., Vasquez J., Miller N.J., et al. Decreased survival of B cells of HIV-viremic patients mediated by altered expression of receptors of the TNF superfamily. J Exp Med 200 (2004) 587-599
19. Margolick J.B., Munoz A., Donnenberg A.D., Park L.P., Galai N., Giorgi J.V., et al. Failure of T-cell homeostasis preceding AIDS in HIV-1 infection. The Multicenter AIDS Cohort Study. Nat Med 1 (1995) 674-680
20. Malaspina A., Moir S., Ho J., Wang W., Howell M.L., O'Shea M.A., et al. Appearance of immature/transitional B cells in HIV-infected individuals with advanced disease: correlation with increased IL-7. Proc Natl Acad Sci U S A 103 (2006) 2262-2267
21. Moir S., Malaspina A., Li Y., Chun T.W., Lowe T., Adelsberger J., et al. B cells of HIV-1-infected patients bind virions through CD21-complement interactions and transmit infectious virus to activated T cells. J Exp Med 192 (2000) 637-646
22. Stoiber H., Speth C., and Dierich M.P. Role of complement in the control of HIV dynamics and pathogenesis. Vaccine 21 suppl 2 (2003) S77-S82
23. Malaspina A., Moir S., Nickle D.C., Donoghue E.T., Ogwaro K.M., Ehler L.A., et al. Human immunodeficiency virus type 1 bound to B cells: relationship to virus replicating in CD4+ T cells and circulating in plasma. J Virol 76 (2002) 8855-8863
24. Rickert R.C. Regulation of B lymphocyte activation by complement C3 and the B cell coreceptor complex. Curr Opin Immunol 17 (2005) 237-243
25. Dorner T., and Radbruch A. Antibodies and B cell memory in viral immunity. Immunity 27 (2007) 384-392
26. Berberian L., Goodglick L., Kipps T.J., and Braun J. Immunoglobulin VH3 gene products: natural ligands for HIV gp120. Science 261 (1993) 1588-1591
27. Juompan L., Lambin P., and Zouali M. Selective alterations of the antibody response to HIV-1. Appl Biochem Biotechnol 75 (1998) 139-150
28. Scamurra R.W., Miller D.J., Dahl L., Abrahamsen M., Kapur V., Wahl S.M., et al. Impact of HIV-1 infection on VH3 gene repertoire of naive human B cells. J Immunol 164 (2000) 5482-5491
29. Margolin D.H., Reimann K.A., Sodroski J., Karlsson G.B., Tenner-Racz K., Racz P., et al. Immunoglobulin V(H) usage during primary infection of rhesus monkeys with chimeric simian-human immunodeficiency viruses. J Virol 71 (1997) 8582-8591
30. De Milito A., Morch C., Sonnerborg A., and Chiodi F. Loss of memory (CD27) B lymphocytes in HIV-1 infection. AIDS 15 (2001) 957-964
31. Nagase H., Agematsu K., Kitano K., Takamoto M., Okubo Y., Komiyama A., et al. Mechanism of hypergammaglobulinemia by HIV infection: circulating memory B-cell reduction with plasmacytosis. Clin Immunol 100 (2001) 250-259
32. Avery D.T., Ellyard J.I., Mackay F., Corcoran L.M., Hodgkin P.D., and Tangye S.G. Increased expression of CD27 on activated human memory B cells correlates with their commitment to the plasma cell lineage. J Immunol 174 (2005) 4034-4042
33. Anderson S.M., Tomayko M.M., and Shlomchik M.J. Intrinsic properties of human and murine memory B cells. Immunol Rev 211 (2006) 280-294
34. Klein U., Rajewsky K., and Kuppers R. Human immunoglobulin (Ig)M+IgD+ peripheral blood B cells expressing the CD27 cell surface antigen carry somatically mutated variable region genes: CD27 as a general marker for somatically mutated (memory) B cells. J Exp Med 188 (1998) 1679-1689
35. Moir S., Malaspina A., Ho J., Wang W., DiPoto A.C., O'Shea M.A., et al. Normalization of B cell counts and subpopulations following antiretroviral therapy in chronic HIV disease. J Infect Dis 197 (2008) 572-579
36. D'Orsogna L.J., Krueger R.G., McKinnon E.J., and French M.A. Circulating memory B-cell subpopulations are affected differently by HIV infection and antiretroviral therapy. AIDS 21 (2007) 1747-1752
37. Chong Y., Ikematsu H., Kikuchi K., Yamamoto M., Murata M., Nishimura M., et al. Selective CD27+ (memory) B cell reduction and characteristic B cell alteration in drug-naive and HAART-treated HIV type 1-infected patients. AIDS Res Hum Retroviruses 20 (2004) 219-226
38. Titanji K., Chiodi F., Bellocco R., Schepis D., Osorio L., Tassandin C., et al. Primary HIV-1 infection sets the stage for important B lymphocyte dysfunctions. AIDS 19 (2005) 1947-1955
39. Ehrhardt G.R., Hsu J.T., Gartland L., Leu C.M., Zhang S., Davis R.S., et al. Expression of the immunoregulatory molecule FcRH4 defines a distinctive tissue-based population of memory B cells. J Exp Med 202 (2005) 783-791
40. Moir S., Ho J., Malaspina A., Wang W., DiPoto A., O'Shea M.A., et al. Evidence for HIV-associated B-cell exhaustion in a dysfunctional memory B-cell compartment in HIV-infected viremic individuals. J Exp Med (2008) In press
41. Sims G.P., Ettinger R., Shirota Y., Yarboro C.H., Illei G.G., and Lipsky P.E. Identification and characterization of circulating human transitional B cells. Blood 105 (2005) 4390-4398
42. Cuss A.K., Avery D.T., Cannons J.L., Yu L.J., Nichols K.E., Shaw P.J., et al. Expansion of functionally immature transitional B cells is associated with human-immunodeficient states characterized by impaired humoral immunity. J Immunol 176 (2006) 1506-1516
43. Malaspina A., Moir S., Chaitt D.G., Rehm C.A., Kottilil S., Falloon J., et al. Idiopathic CD4+ T lymphocytopenia is associated with increases in immature/transitional B cells and serum levels of IL-7. Blood 109 (2007) 2086-2088
44. Napolitano L.A., Grant R.M., Deeks S.G., Schmidt D., De Rosa S.C., Herzenberg L.A., et al. Increased production of IL-7 accompanies HIV-1-mediated T-cell depletion: implications for T-cell homeostasis. Nat Med 7 (2001) 73-79
45. Fry T.J., Connick E., Falloon J., Lederman M.M., Liewehr D.J., Spritzler J., et al. A potential role for interleukin-7 in T-cell homeostasis. Blood 97 (2001) 2983-2990
46. McCune J.M. The dynamics of CD4+ T-cell depletion in HIV disease. Nature 410 (2001) 974-979
47. Siegel R.M. Caspases at the crossroads of immune-cell life and death. Nat Rev Immunol 6 (2006) 308-317
48. Ho J., Moir S., Malaspina A., Howell M.L., Wang W., DiPoto A.C., et al. Two overrepresented B cell populations in HIV-infected individuals undergo apoptosis by different mechanisms. Proc Natl Acad Sci U S A 103 (2006) 19436-19441
49. Bekker V., Scherpbier H., Beld M., Piriou E., van Breda A., Lange J., et al. Epstein-Barr virus infects B and non-B lymphocytes in HIV-1-infected children and adolescents. J Infect Dis 194 (2006) 1323-1330
50. Soriano-Sarabia N., Leal M., Delgado C., Molina-Pinelo S., De Felipe B., Ruiz-Mateos E., et al. Effect of hepatitis C virus coinfection on humoral immune alterations in naive HIV-infected adults on HAART: a three year follow-up study. J Clin Immunol 25 (2005) 296-302
51. De Boer R.J., Mohri H., Ho D.D., and Perelson A.S. Turnover rates of B cells, T cells, and NK cells in simian immunodeficiency virus-infected and uninfected rhesus macaques. J Immunol 170 (2003) 2479-2487
52. Hazenberg M.D., Stuart J.W., Otto S.A., Borleffs J.C., Boucher C.A., de Boer R.J., et al. T-cell division in human immunodeficiency virus (HIV)-1 infection is mainly due to immune activation: a longitudinal analysis in patients before and during highly active antiretroviral therapy (HAART). Blood 95 (2000) 249-255
53. Kovacs J.A., Lempicki R.A., Sidorov I.A., Adelsberger J.W., Herpin B., Metcalf J.A., et al. Identification of dynamically distinct subpopulations of T lymphocytes that are differentially affected by HIV. J Exp Med 194 (2001) 1731-1741
54. Lempicki R.A., Kovacs J.A., Baseler M.W., Adelsberger J.W., Dewar R.L., Natarajan V., et al. Impact of HIV-1 infection and highly active antiretroviral therapy on the kinetics of CD4+ and CD8+ T cell turnover in HIV-infected patients. Proc Natl Acad Sci U S A 97 (2000) 13778-13783
55. Mohri H., Bonhoeffer S., Monard S., Perelson A.S., and Ho D.D. Rapid turnover of T lymphocytes in SIV-infected rhesus macaques. Science 279 (1998) 1223-1227
56. Sachsenberg N., Perelson A.S., Yerly S., Schockmel G.A., Leduc D., Hirschel B., et al. Turnover of CD4+ and CD8+ T lymphocytes in HIV-1 infection as measured by Ki-67 antigen. J Exp Med 187 (1998) 1295-1303
57. Der S.D., Zhou A., Williams B.R., and Silverman R.H. Identification of genes differentially regulated by interferon alpha, beta, or gamma using oligonucleotide arrays. Proc Natl Acad Sci U S A 95 (1998) 15623-15628
58. Samuelsson A., Sonnerborg A., Heuts N., Coster J., and Chiodi F. Progressive B cell apoptosis and expression of Fas ligand during human immunodeficiency virus type 1 infection. AIDS Res Hum Retroviruses 13 (1997) 1031-1038
59. Muro-Cacho C.A., Pantaleo G., and Fauci A.S. Analysis of apoptosis in lymph nodes of HIV-infected persons: intensity of apoptosis correlates with the general state of activation of the lymphoid tissue and not with stage of disease or viral burden. J Immunol 154 (1995) 5555-5566
60. Greenwald R.J., Freeman G.J., and Sharpe A.H. The B7 family revisited. Annu Rev Immunol 23 (2005) 515-548
61. Malaspina A., Moir S., Kottilil S., Hallahan C.W., Ehler L.A., Liu S., et al. Deleterious effect of HIV-1 plasma viremia on B cell costimulatory function. J Immunol 170 (2003) 5965-5972
62. Moir S., Ogwaro K.M., Malaspina A., Vasquez J., Donoghue E.T., Hallahan C.W., et al. Perturbations in B cell responsiveness to CD4+ T cell help in HIV-infected individuals. Proc Natl Acad Sci U S A 100 (2003) 6057-6062
63. Malaspina A., Moir S., Orsega S.M., Vasquez J., Miller N.J., Donoghue E.T., et al. Compromised B cell responses to influenza vaccination in HIV-infected individuals. J Infect Dis 191 (2005) 1442-1450
64. Titanji K., De Milito A., Cagigi A., Thorstensson R., Grutzmeier S., Atlas A., et al. Loss of memory B cells impairs maintenance of long-term serologic memory during HIV-1 infection. Blood 108 (2006) 1580-1587
65. Hart M., Steel A., Clark S.A., Moyle G., Nelson M., Henderson D.C., et al. Loss of discrete memory B cell subsets is associated with impaired immunization responses in HIV-1 infection and may be a risk factor for invasive pneumococcal disease. J Immunol 178 (2007) 8212-8220
66. Kruetzmann S., Rosado M.M., Weber H., Germing U., Tournilhac O., Peter H.H., et al. Human immunoglobulin M memory B cells controlling Streptococcus pneumoniae infections are generated in the spleen. J Exp Med 197 (2003) 939-945
67. Shearer W.T., Easley K.A., Goldfarb J., Rosenblatt H.M., Jenson H.B., Kovacs A., et al. Prospective 5-year study of peripheral blood CD4, CD8, and CD19/CD20 lymphocytes and serum Igs in children born to HIV-1 women. The P(2)C(2) HIV Study Group. J Allergy Clin Immunol 106 (2000) 559-566
68. Bekker V., Scherpbier H., Pajkrt D., Jurriaans S., Zaaijer H., and Kuijpers T.W. Persistent humoral immune defect in highly active antiretroviral therapy-treated children with HIV-1 infection: loss of specific antibodies against attenuated vaccine strains and natural viral infection. Pediatrics 118 (2006) e315-e322
69. Bliss S.J., O'Brien K.L., Janoff E.N., Cotton M.F., Musoke P., Coovadia H., et al. The evidence for using conjugate vaccines to protect HIV-infected children against pneumococcal disease. Lancet Infect Dis 8 (2008) 67-80
70. Obaro S.K., Pugatch D., and Luzuriaga K. Immunogenicity and efficacy of childhood vaccines in HIV-1-infected children. Lancet Infect Dis 4 (2004) 510-518
71. Dankner W.M., Lindsey J.C., and Levin M.J. Correlates of opportunistic infections in children infected with the human immunodeficiency virus managed before highly active antiretroviral therapy. Pediatr Infect Dis J 20 (2001) 40-48
72. Hatherill M. Sepsis predisposition in children with human immunodeficiency virus. Pediatr Crit Care Med 6 (2005) S92-S98
73. Mascola J.R., Lewis M.G., Stiegler G., Harris D., VanCott T.C., Hayes D., et al. Protection of macaques against pathogenic simian/human immunodeficiency virus 89.6PD by passive transfer of neutralizing antibodies. J Virol 73 (1999) 4009-4018
74. Miller C.J., Genesca M., Abel K., Montefiori D., Forthal D., Bost K., et al. Antiviral antibodies are necessary for control of simian immunodeficiency virus replication. J Virol 81 (2007) 5024-5035
75. Baba T.W., Liska V., Hofmann-Lehmann R., Vlasak J., Xu W., Ayehunie S., et al. Human neutralizing monoclonal antibodies of the IgG1 subtype protect against mucosal simian-human immunodeficiency virus infection. Nat Med 6 (2000) 200-206
76. Johnston M.I., and Fauci A.S. An HIV vaccine: evolving concepts. N Engl J Med 356 (2007) 2073-2081
77. Letvin N.L. Progress and obstacles in the development of an AIDS vaccine. Nat Rev Immunol 6 (2006) 930-939
78. Montefiori D., Sattentau Q., Flores J., Esparza J., and Mascola J. Antibody-based HIV-1 vaccines: recent developments and future directions. PLoS Med 4 (2007) e348
79. Li Y., Migueles S.A., Welcher B., Svehla K., Phogat A., Louder M.K., et al. Broad HIV-1 neutralization mediated by CD4-binding site antibodies. Nat Med 13 (2007) 1032-1034
80. Karlsson Hedestam G.B., Fouchier R.A., Phogat S., Burton D.R., Sodroski J., and Wyatt R.T. The challenges of eliciting neutralizing antibodies to HIV-1 and to influenza virus. Nat Rev Microbiol 6 (2008) 143-155